This topic contains a solution. Click here to go to the answer

Author Question: In order to confirm a research hypothesis in a factorial design there must be both a. a correct ... (Read 76 times)

Kikoku

  • Hero Member
  • *****
  • Posts: 540
In order to confirm a research hypothesis in a factorial design there must be both
 
  a. a correct research hypothesis and a significant interaction.
  b. a Type 1 and a Type 2 error.
  c. a p-value and a two-tailed test.
  d. a significant interaction and a predicted pattern of observed means.

Question 2

Which of the following is likely to decrease experimentwise alpha in a factorial design?
 
  a. Adding more factors
  b. Adding more levels to each factor
  c. Using post hoc rather than a priori comparisons
  d. Making all possible cell comparisons



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

billybob123

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

d

Answer to Question 2

c





 

Did you know?

There are immediate benefits of chiropractic adjustments that are visible via magnetic resonance imaging (MRI). It shows that spinal manipulation therapy is effective in decreasing pain and increasing the gaps between the vertebrae, reducing pressure that leads to pain.

Did you know?

Cocaine was isolated in 1860 and first used as a local anesthetic in 1884. Its first clinical use was by Sigmund Freud to wean a patient from morphine addiction. The fictional character Sherlock Holmes was supposed to be addicted to cocaine by injection.

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library